1. Home
  2. GSL vs STAA Comparison

GSL vs STAA Comparison

Compare GSL & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSL

Global Ship Lease Inc New

HOLD

Current Price

$44.48

Market Cap

1.5B

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$23.52

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSL
STAA
Founded
2007
1982
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
GSL
STAA
Price
$44.48
$23.52
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$44.00
$22.81
AVG Volume (30 Days)
363.5K
852.7K
Earning Date
05-18-2026
05-12-2026
Dividend Yield
6.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
N/A
$239,442,000.00
Revenue This Year
N/A
$30.82
Revenue Next Year
N/A
$8.41
P/E Ratio
$3.49
$86.88
Revenue Growth
N/A
N/A
52 Week Low
$27.28
$15.59
52 Week High
$45.45
$35.87

Technical Indicators

Market Signals
Indicator
GSL
STAA
Relative Strength Index (RSI) 59.19 45.76
Support Level $37.00 $23.27
Resistance Level $45.07 $26.21
Average True Range (ATR) 0.98 1.14
MACD 0.05 -0.03
Stochastic Oscillator 75.63 36.87

Price Performance

Historical Comparison
GSL
STAA

About GSL Global Ship Lease Inc New

Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Share on Social Networks: